Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Reference35 articles.
1. Effect of deprenyl on the progression of disability in early Parkinson's disease;Parkinson Study Group;N Engl J Med,1989
2. Comparison of the therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease;Lees;Br Med J,1995
3. Selegiline slows the progression of the symptoms of Parkinson disease;Palhagen;Neurology,2006
4. Monoamine oxidase B inhibitor therapy in early Parkinson's disease: a systematic review of randomised controlled trials;Ives;BMJ,2004
5. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study;Whone;Ann Neurol,2003
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?;Expert Review of Neurotherapeutics;2023-02-01
2. Neuroprotective Effects of Intermittent Theta Burst Stimulation in Parkinson’s Disease (NET-PD): A Study Protocol for a Delayed-Start Randomized Double-Blind Sham-Controlled Trial;Journal of Clinical Medicine;2022-08-24
3. Designs to Detect Disease Modification;Principles and Practice of Clinical Trials;2022
4. Designs to Detect Disease Modification;Principles and Practice of Clinical Trials;2021
5. New perspectives in iron chelation therapy for the treatment of Parkinson’s disease;Neural Regeneration Research;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3